殼聚糖交聯(lián)微球的制備
[Abstract]:Microsphere dosage form is one of the key directions of the present preparation. The microspheres can reduce the degradation rate of the medicine and improve the stability of the medicine. The microspheres prepared by the single cross-linking agent have good slow-release property, but can not realize effective controlled release. In this paper,5-fluorouramide drug-loaded microspheres were prepared by cross-linking of Beijing-Niping and vanillin, and the release rate of the microspheres was controlled by adjusting the cross-linking agent. In this paper, the conditions of the preparation of microspheres by a single cross-linking agent are selected. On the basis of this condition, the optimal conditions for preparing the microspheres by the compound cross-linking agent were determined, and the drug-loaded microspheres were prepared by adding 5-fluorouramide. The highest drug-carrying amount of the drug-loaded microspheres was 2.97% and the encapsulation rate was 20.27% by HPLC. The prepared microspheres have good dispersivity and uniform particle size distribution, and the particle size range is about 10-20 & mu; m; and the FT-IR spectrum results show that both the Jingyi and the vanillin are cross-linked with the chitosan; and the swelling performance results show that the swelling rate of the microspheres prepared by the cross-linking agent of different compounding proportions is different, The results show that the microspheres have different release rates. The results of the XRD pattern show that the microspheres were successfully cross-linked, and the DSC-TGA pattern confirmed that the 5-fluorouramide was inside the microspheres, and the stability of the 5-fluorouramide was improved. With reference to the existing national standard, the release performance of 5-fluorouramide drug-loaded microspheres was studied. The maximum cumulative release rate of the microballoon was 97.2% in the buffer solution of pH = 3.6, and the maximum cumulative release rate was 94.2% in the buffer solution of pH = 7.4. Therefore, the effect of controlling the release rate can be achieved by controlling the compounding ratio of the cross-linking agent. The stability of the microspheres was studied under the conditions of high temperature, high light and high humidity.
【學(xué)位授予單位】:河北科技大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:TQ460.1;O636.1
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王笛笛;管冬冬;田珊;韓順玉;;殼聚糖功能化修飾的復(fù)合微球研究進(jìn)展[J];廣東化工;2017年01期
2 吳成城;賈子平;馮敬飛;胡連升;;Rathke囊腫的診斷和手術(shù)治療[J];中國(guó)冶金工業(yè)醫(yī)學(xué)雜志;2016年06期
3 劉德杰;張慧;安飛;翟光喜;;生物黏附微球的研究進(jìn)展[J];藥學(xué)研究;2016年08期
4 孫智純;王兵;單娟娟;司匯通;;香草醛分子印跡聚合物微球的合成及表征[J];現(xiàn)代食品科技;2015年09期
5 趙崇濤;張立英;;我國(guó)兒童腫瘤疾病的發(fā)展?fàn)顩r及預(yù)防的初探[J];中國(guó)民康醫(yī)學(xué);2015年12期
6 馮淑瑩;;殼聚糖載藥微球的制備及其應(yīng)用進(jìn)展[J];廣東化工;2015年07期
7 趙暖暖;仵文英;張抗懷;王娜;;HPLC法測(cè)定5-氟尿嘧啶納米粒的藥物包封率[J];藥物分析雜志;2014年05期
8 熊華;胡振瀛;王素芳;彭海龍;;京尼平交聯(lián)殼聚糖微球的制備及理化性質(zhì)[J];南昌大學(xué)學(xué)報(bào)(工科版);2013年04期
9 楊子明;彭政;周敏;李思東;龐玉新;李虹;李普旺;;殼聚糖靶向緩釋功能高分子載藥微球及其特性研究[J];功能材料;2013年12期
10 王忠云;楊秀芹;楊君東;李曉劍;;5-氟尿嘧啶配制時(shí)間與藥物穩(wěn)定性研究[J];中國(guó)醫(yī)藥科學(xué);2012年18期
相關(guān)碩士學(xué)位論文 前2條
1 張溢瓊;基于核殼結(jié)構(gòu)的納微粒程序性控制給藥系統(tǒng)的研究[D];重慶大學(xué);2011年
2 王媛媛;抗腫瘤藥物(5-氟尿嘧啶)的緩釋作用研究[D];東北師范大學(xué);2010年
,本文編號(hào):2486116
本文鏈接:http://sikaile.net/kejilunwen/huaxue/2486116.html